Chromium Patents (Class 424/655)
-
Publication number: 20120148648Abstract: A composition comprising a pigment particle that is coated with a cationic material and isopropyl titanium triisostearate. The pigment particle can be included in a cleansing composition for deposition on a surface, such as skin.Type: ApplicationFiled: August 31, 2009Publication date: June 14, 2012Applicants: Kobo Products Inc., Cologate-Palmolive CompanyInventors: Yun Shao, David Schlossman, Neringa Kontrimiene, Ariel Haskel
-
Publication number: 20120141448Abstract: Phosphatidic acid is administered orally to increase muscle mass and strength in exercising mammals. Phosphatidic acid is administered orally to aging, bedridden or cachectic patients to improve nitrogen balance. The preferred form of phosphatidic acid for administration is phosphatidic acid-enriched lecithin. Creatine is co-administered orally to increase the muscle-building and strength effect. Other suggested additives include nutritional and herbal supplements, micronutrients and hormones.Type: ApplicationFiled: November 23, 2011Publication date: June 7, 2012Inventors: Lorenzo De Ferra, Marvin Heuer, Scott Hagerman, Martin Purpura, Ralf Jäger
-
Publication number: 20120128794Abstract: Provided herein are compositions for the administration of chromium that include at least two components: a hydrophilic chromium complex and a lipophilic chromium complex, and methods of using the same. Also provided are compositions for the administration of chromium that include a first “fast-acting” chromium complex and a second “slow-acting” chromium complex, wherein the first chromium complex is absorbed more quickly than the slow-acting chromium complex, and methods of using the same. Also provided herein are methods for treating, preventing, and improving conditions associated with cardiometabolic syndrome, by identifying a subject in need of treatment, prevention, or improvement of a condition associated with cardiometabolic syndrome, and providing a therapeutically effective amount of a composition comprising a fast-acting chromium complex and a slow-acting chromium complex, to the individual.Type: ApplicationFiled: November 18, 2011Publication date: May 24, 2012Applicant: NUTRITION 21, INC.Inventor: James R. Komorowski
-
Publication number: 20120100228Abstract: The embodiments disclosed herein relate to compositions for enhancing brain glucose transporters, such as GLUT1 and GLUT3, and methods of treating and/or preventing diseases or disorders associated with the regulation GLUT1 and GLUT3. Also provided are compositions that include chromium and an agent that targets the brain or the central nervous system. Further provided are improved methods of delivering therapeutic agents that target the brain and/or central nervous system.Type: ApplicationFiled: June 30, 2010Publication date: April 26, 2012Inventor: James R. Komorowski
-
Publication number: 20120087877Abstract: The invention relates to a composition based on mineral concentrates and a method of preparing this composition. The composition comprises a powder or a mixture of powders containing at least one silicon derivative and at least one trace element other than silicon, as a mixture with a carrier and physiologically acceptable excipients. Application in cosmetology and dermatology for protecting the skin.Type: ApplicationFiled: October 14, 2011Publication date: April 12, 2012Applicant: BULGARI PARFUMSInventors: Jean-Claude ALLART, Jean-Marie Lefevre, Jacques Peyrot, Jean-Paul Marty
-
Patent number: 8142800Abstract: A practical high potency anti-craving oral medication or combined oral/IV drip medication is disclosed which comprises three components: a group of amino-acid substances, a group of vitamin substances, and a group of minerals, wherein each substance is selected for maximum efficacy in the body of an individual suffering from substance abuse disorder as opposed to the body of a healthy individual. The ingredients of the invention are selected to cooperate in easing metabolization in the bodies of individuals suffering the various medical conditions associated with substance abuse. The ingredients are provided orally to ease administration and to provide convenient use by patients: the oral medication may be a maintenance dosage or a corrective dosage.Type: GrantFiled: September 14, 2006Date of Patent: March 27, 2012Inventors: Tamea Rae Sisco, Keith Kenneth Skinner, Theodore Keller
-
Patent number: 8142799Abstract: A practical high potency anti-craving medication is disclosed which comprises three components: an amino-acid component, a vitamin component, and a mineral component, wherein each component is selected for maximum efficacy in the body of an individual suffering from substance abuse disorder as opposed to the body of a healthy individual. Additionally, the active agents are received by means of a prolonged administration, preferably by means of an IV drip, thus assuring a period of time in which the active agents are present in desired concentrations, and more preferably a prolonged time during which they are simultaneously present in desired concentrations. The agents of each component are also selected so as to allow easy administration of the medication to patients in three vials of medication rather than as a large number of individual vials.Type: GrantFiled: August 20, 2005Date of Patent: March 27, 2012Inventors: Tamea Rae Sisco, Keith Kenneth Skinner, Theodore R Keller
-
Publication number: 20120064176Abstract: A composition for preventing and treating fatty liver is disclosed. The composition includes a lactoferrin and a trivalent chromium compound. The trivalent chromium compound of the present invention is selected from the group consisting of chromium (III) chloride hexahydrate, chromium (III) chloride, chromium (III) acetate, chromium (III) sulfate, chromium picolinate, chromium nicotinate, chromium GTF, chromium yeast extract, other inorganic salts of trivalent chromium, other organic salts of trivalent chromium, and combinations thereof. The composition of the present invention can provide a beneficial effect in preventing and treating fatty liver by effectively reducing multiple risk factors of fatty liver disease.Type: ApplicationFiled: November 21, 2011Publication date: March 15, 2012Applicant: National Chung Hsing UniversityInventors: Frank Chiahung MAO, Wen-Ying Chen
-
Publication number: 20120059307Abstract: Provided are nanoparticles and formulations which are useful for cosmetic, diagnostic and therapeutic applications to mammals such as humans.Type: ApplicationFiled: August 26, 2011Publication date: March 8, 2012Applicant: SIENNA LABS, INC.Inventors: Todd James Harris, Alice Ann Chen
-
Patent number: 8062677Abstract: Provided herein are compositions for the administration of chromium that include at least two components: a hydrophilic chromium complex and a lipophilic chromium complex, and methods of using the same. Also provided are compositions for the administration of chromium that include a first “fast-acting” chromium complex and a second “slow-acting” chromium complex, wherein the first chromium complex is absorbed more quickly than the slow-acting chromium complex, and methods of using the same. Also provided herein are methods for treating, preventing, and improving conditions associated with cardiometabolic syndrome, by identifying a subject in need of treatment, prevention, or improvement of a condition associated with cardiometabolic syndrome, and providing a therapeutically effective amount of a composition comprising a fast-acting chromium complex and a slow-acting chromium complex, to the individual.Type: GrantFiled: December 19, 2008Date of Patent: November 22, 2011Assignee: Nutrition 21, Inc.Inventor: James R. Komorowski
-
Publication number: 20110280958Abstract: The present invention relates to active compound combinations, in particular within a fungicide composition, which comprises (A) a dithiino-tetracarboximide of formula (I) and a metal salt (B). Moreover, the invention relates to a method for curatively or preventively controlling the phytopathogenic fungi of plants or crops, to the use of a combination according to the invention for the treatment of seed, to a method for protecting a seed and not at least to the treated seed. In particular the combinations according to the invention are useful to obtain plants with greener leaf color.Type: ApplicationFiled: April 14, 2011Publication date: November 17, 2011Applicant: Bayer CropScience AGInventors: Thomas Seitz, Ulrike Wachendorff-Neumann
-
Publication number: 20110256194Abstract: The present invention relates to a pearl pigment obtained by coating the surface of a flaky powder with a colored metal or a colored metal oxide and further coating the surface of the above colored metal- or colored metal oxide-coated flaky powder with a colorless metal or a colorless metal oxide, wherein when the pearl pigment is applied onto the surface of black artificial leather in an average amount of 0.05 mg/cm2 and the intensity of light reflected from the pearl pigment is measured using illuminant C at a 2° viewing angle with a spectrophotometric colorimeter which is provided with a sheet polarizer S on the light incident side and a sheet polarizer P on the light receiving side, the powder reflection light which is incident to the pearl pigment as a measurement sample at an angle of 45° to the direction normal to the surface of the sample and is received in the direction normal to the surface of the sample has absolute values a* and b* of 10 or less, and make-up cosmetics containing the pearl pigment.Type: ApplicationFiled: June 28, 2011Publication date: October 20, 2011Applicants: Nihon Koken Kogyo KK, Kao CorporationInventors: Eiichiro MISAKI, Hiroyuki SHIOMI, Maoya ADACHI, Takahiro KAIDA
-
Publication number: 20110217389Abstract: Methods of treating, reducing, and/or preventing heat stress are provided. For example, provided is a method of treating or preventing heat stress in a subject comprising selecting a subject in need of heat stress treatment or prevention and administering an effective amount of one or more of astaxanthin and milk casein hydrolysate, or a derivative thereof to the subject. Also provided are methods of reducing the effects of a fever in a subject comprising administering an effective amount of one or more of astaxanthin, chromium and milk casein hydrolysate, or a derivative thereof, to the subject. Also provided are pharmaceutical compositions, comprising astaxanthin and one or more of chromium or milk casein hydrolysate.Type: ApplicationFiled: April 8, 2010Publication date: September 8, 2011Applicant: GEORGETOWN UNIVERSITYInventor: Harry George Preuss
-
Patent number: 7993630Abstract: The present invention discloses certain heterocyclic complexes of metals of formula (I), especially those of manganese, which enhance the safety and efficacy of sunscreens via urocanate pathway modulation.Type: GrantFiled: July 4, 2009Date of Patent: August 9, 2011Assignee: Bioderm ResearchInventor: Shyam K Gupta
-
Publication number: 20110190566Abstract: The present invention relates to polymer microgel beads having a polymeric matrix with nanomagnetic particles dispersed substantially uniformly therethrough, wherein a steric stabiliser is associated with the particles, the steric stabiliser being a polymeric material that (i) does not form part of the polymeric matrix of the beads, and (ii) comprises a steric stabilising polymeric segment and an anchoring polymeric segment, wherein the steric stabilising polymeric segment is different from the anchoring polymeric segment, and wherein the anchoring polymeric segment has an affinity toward the surface of the nanomagnetic particles and secures the stabiliser to the particles.Type: ApplicationFiled: May 15, 2009Publication date: August 4, 2011Applicant: University Of SydneyInventors: Brian Stanley Hawkett, Nirmesh Jain
-
Publication number: 20110189161Abstract: The present invention provides a proprietary compositions and systems to modulate genetic and metabolomic contributing factors affecting disease diagnosis, stratification, and prognosis, as well as the metabolism, efficacy and/or toxicity associated with specific vitamins, minerals, herbal supplements, homeopathic ingredients, and other ingredients for the purposes of customizing a subject's nutritional supplement formulation to optimize specific health outcomes. Specific to this invention the utilization of certain known polymorphic genes associated with Substance Use Disorder (SUD) are analyzed to target certain genetic anomalies that lead to a high risk and predisposition to SUD. The genotypic patterns are then utilized to provide certain nutritional customized solutions especially related to the attenuation of aberrant abuse of physician prescribed narcotic pain medication across all pain conditions.Type: ApplicationFiled: June 22, 2009Publication date: August 4, 2011Inventors: Kenneth Blum, Roger L. Waite, B. William Downs, William J. Heaney
-
Patent number: 7964220Abstract: Several classes of in vivo carbon monoxide-releasing compounds are useful for the treatment and/or prevention of diseases, such as chronic inflammatory, e.g., rheumatoid arthritis, and of diseases with a strong inflammatory component, such as atherosclerosis, stroke, coronary disease, and Alzheimers disease. The in vivo carbon monoxide-releasing compounds can be attached to known drug vectors and/or known anti-inflammatory drugs, such as aspirin.Type: GrantFiled: June 14, 2006Date of Patent: June 21, 2011Assignee: ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda.Inventors: Werner E. Haas, Carlos C. Romao, Beatriz Royo, Ana Cristina Fernandes, Isabel Goncalves
-
Publication number: 20110097366Abstract: Goniochromatic/light reflecting cosmetic compositions well suited for making up the skin, lips, hair or integuments, contain (a) at least one goniochromatic coloring agent and (b) an amount of light reflective particles different from said at least one goniochromatic coloring agent and selected from the group consisting of (i) particles of a natural or synthetic substrate at least partially coated with at least one layer of at least one metal, (ii) particles of a synthetic substrate at least partially coated with at least one layer of at least one metallic compound, (iii) particles which comprise a stack of at least two layers of materials having different refractive indices, at least one of such layers optionally comprising a polymer, and (iv) metal oxide particles, formulated into (c) a topically applicable, physiologically acceptable medium therefor.Type: ApplicationFiled: July 30, 2010Publication date: April 28, 2011Applicant: Societe L'Oreal, S.A.Inventors: Jean-Christophe Simon, Franck Girier-Dufournier, Patricia Lemann
-
Patent number: 7910137Abstract: Metal carnitine chelates comprising carnitine chelated to a nutritionally relevant metal can be used for general nutrition as well as well as to treat a variety of health related problems and symptoms. For example, metal carnitine chelates can be used to maintain good cardiovascular health, increase male fertility, enhance weight loss, provide mineral and/or carnitine supplements for mineral- and/or carnitine-deficient subjects, and reduce alcohol dependency and associated symptoms. Nutritionally relevant metals that can be used include copper, zinc, magnesium, calcium, iron, chromium, and manganese, to name a few.Type: GrantFiled: July 7, 2006Date of Patent: March 22, 2011Assignee: Albion International, Inc.Inventors: H. DeWayne Ashmead, R. Charles Thompson
-
Patent number: 7887848Abstract: In an embodiment of the present invention, a nutraceutical formula comprising a combination of chromium, zinc, berry extract, Polygonum cuspidatum extract, aloe vera, chlorophyll and L-arginine combined synergistically to reduce inflammation in mammals suffering from diabetes. In another embodiment of the present invention, a nutraceutical formula comprising a of zinc, chromium, berry extract, Polygonum cuspidatum extract, aloe vera, chlorophyll and L-arginine combined synergistically to enhance wound healing in mammals suffering from diabetes. In an alternative embodiment of the present invention, a nutraceutical formula comprising a of zinc, chromium, berry extract, Polygonum cuspidatum extractive, aloe vera, chlorophyll and L-arginine combined synergistically to reduce inflammation in mammals not suffering from diabetes.Type: GrantFiled: May 31, 2007Date of Patent: February 15, 2011Assignee: Interhealth Nutraceuticals, Inc.Inventors: Xiaoming Xu Chien, Debasis Bagchi
-
Patent number: 7879367Abstract: The invention relates to a medical implant made of a metallic material. After fulfilling its temporary support function, the implant is degraded by corrosion at a predetermined rate. Negative long-term effects are thus avoided.Type: GrantFiled: July 17, 1998Date of Patent: February 1, 2011Assignees: Alfons Fischer, Jacqueline Hausdorf, Eva HeubleinInventors: Bernd Heublein, Gerd Hausdorf
-
Publication number: 20110020471Abstract: Erythrocyte ATP-release modulators and composition and methods for their use to potentiate serum glucose clearance and vasodilation; methods for prophylactic or palliative therapy of glucose processing or vascular disorders; processes for preparing the modulators and compositions comprising them; and kits therefor.Type: ApplicationFiled: September 23, 2009Publication date: January 27, 2011Applicants: Wayne State University, Board of Directors of Michigan State UniversityInventors: Dana Spence, Gavin Edmund Reid
-
Publication number: 20100323031Abstract: The present disclosure discloses a synergistic combination comprising (?)-hydroxycitric acid, bitter melon extract and sesame seed lignans extract to enhance blood glucose and insulin metabolism. The synergistic combination also reduces reactive hypoglycemia in those who are insulin resistant.Type: ApplicationFiled: June 22, 2009Publication date: December 23, 2010Applicant: GLYKON TECHNOLOGIES GROUP, LLCInventors: Daniel Elliot Clouatre, Dallas Lavoe Clouatre
-
Publication number: 20100316734Abstract: Methods and systems for treatment based on thermographic images of a patient to detect temperature patterns indicative of an evolving disease process. Guided by the thermographic image obtained, a treatment means can be positioned on the skin of the imaged body part. The treatment means comprises a medicament that reduces risk factor(s) associated with the progression of the evolving disease process.Type: ApplicationFiled: August 24, 2010Publication date: December 16, 2010Inventors: Julie Hart, Christopher Cozzie
-
Publication number: 20100297262Abstract: Described herein are pharmaceutical compositions and medicaments, and methods of using such pharmaceutical compositions and medicaments in the treatment of inflammation and cancer.Type: ApplicationFiled: April 16, 2010Publication date: November 25, 2010Applicant: COLBY PHARMACEUTICAL COMPANYInventors: Hirak S. Basu, David A. Zarling
-
Patent number: 7829126Abstract: Disclosed are infant formulas and corresponding methods of using them to promote retinal health and vision development in infants. The formulas, which are free of egg phospholipids and comprise fat, protein, carbohydrate, vitamins, and minerals, including docosahexaenoic acid and, on a ready-to-feed basis, at least about 50 mcg/liter of lutein, wherein the weight ratio of lutein (mcg) to docosahexaenoic acid (mg) is from about 1:2 to about 10:1. The formulas are also believed to be especially useful in reducing the risk of retinopathy of prematurity in preterm infants.Type: GrantFiled: October 20, 2006Date of Patent: November 9, 2010Assignee: Abbott LaboratoriesInventors: Bridget Barrett-Reis, Pamela T. Price, Amy Mackey
-
Publication number: 20100266647Abstract: Compositions comprising a gel system made from a combination of a fractal network of nanoparticles and translucent macroscopic particles, titanium dioxide and other color pigments is disclosed. The compositions are capable of forming an effective film on the biological surface such as skin to blurring fine lines and wrinkles while retaining a natural look of the skin as a consequence of synergy between the fractal particles, the macroscopic particles, titanium dioxide and color pigments. Also disclosed methods for their use.Type: ApplicationFiled: November 14, 2008Publication date: October 21, 2010Applicant: AVON PRODUCTS, INC.Inventors: Ajay G. Dingley, Michael J. Fair, John R. Glynn, JR., Giovana A. Sandstrom
-
Publication number: 20100239663Abstract: This invention relates to a non-toxic composition which bind acetaldehyde present in the stomach, intestine and/or colon. The composition comprises one or more acetaldehyde-binding compound(s) comprising one or more free sulphhydryl and/or amino groups. The compound(s) are mixed with a non-toxic carrier that effects sustained release of said compound(s) in the gastrointestinal tract. This invention relates also to food additives and food compositions and packages comprising the composition.Type: ApplicationFiled: May 22, 2007Publication date: September 23, 2010Applicant: BIOHIT OYJInventors: Osmo Suovaniemi, Ville Salaspuro, Martti Marvola, Mikko Salaspuro
-
Publication number: 20100227001Abstract: A method of delivering nutrients for bariatric patients comprising the sublingual administration of a B-complex vitamin composition and ingesting a liquid, water-soluble multi-vitamin complex orally at approximately the same time. The liquid multi-vitamin is comprised of a plurality of compounds from the group of Vitamin A, Vitamin C, Vitamin D and Vitamin E. After administering the Vitamin B complex and the liquid multi-vitamin, a solid vitamin formulation comprising at least two compounds from the group of iron, zinc, selenium, copper, chromium, Vitamin K, and manganese is ingested orally. A protein solution comprising proteins broken down into small peptide chains, calcium, and fiber may also be delivered orally to the bariatric patient in a liquid form. The method may be repeated once or twice daily. The method of the invention maximizes delivery and absorption of nutrients to the bariatric patient and the tolerance and speed of delivery.Type: ApplicationFiled: March 5, 2009Publication date: September 9, 2010Inventor: SILVIA DEMETER
-
Patent number: 7790209Abstract: The invention provides a total enteral nutritious composition containing proteins, sugars, fats, minerals and vitamins, which improves serum albumin and ameliorates bedsores. The total enteral nutritious composition has a zinc/copper weight ratio of 10-25, and a zinc content of 1.5 mg or greater, a copper content of 0.075-0.15 mg, a sodium content of at least 185 mg, a vitamin B1 content of at least 0.30 mg, a vitamin B2 content of at least 0.25 mg and a protein content of at least 4.0 g, per 100 kcal of the composition. Preferably it has a protein content of at least 5.0 g, a vitamin B6 content of at least 0.30 mg, a biotin content of at least 1.0 ?g, a vitamin B12 content of at least 0.20 ?g, a folic acid content of at least 20 ?g, a ?-carotene content of at least 100 ?g and a vitamin C content of at least 10 mg. Medium-chain fatty acid oils preferably constitute 35% by weight of the fats of the fat source, per 100 kcal of the composition. The preferred composition viscosity is 6-18 mPa·s (25° C.Type: GrantFiled: March 22, 2007Date of Patent: September 7, 2010Assignee: Ajinomoto Co., Inc.Inventors: Toshihiro Ohmori, Naoki Hayashi, Kiyoshi Fujita, Hideki Tanaka, Kazunori Saima, Itaru Kon, Miki Tomoe
-
Publication number: 20100209389Abstract: The invention provides a multi-compartmented container suitable for the delivery of pharmaceuticals, medicines, vitamins, and the like.Type: ApplicationFiled: October 14, 2008Publication date: August 19, 2010Inventors: Clinton Wesley McInnes, Anna Marie Underwood, Phillip Andrew Vickery
-
Publication number: 20100203117Abstract: Herbal compositions are useful for inhibition, amelioration or prevention of adipogenesis mediated diseases such as obesity, lipid storage disease and hyperlipemia. The herbal compositions comprise biologically effective amounts of extracts or fractions from Piper betle in combination with one or more of the extracts or fractions derived from Dolichos biflorus, Commiphora mukul, Boerhaavia diffusa, Tribulus terrestris and Zingiber officinale as active ingredients. The compositions optionally contain a bio-enhancing agent or a bio-protecting agent, along with biologically acceptable carriers or diluents. The herbal compositions may be used in a method for treating or preventing adipogenesis involved diseases in mammals.Type: ApplicationFiled: September 24, 2007Publication date: August 12, 2010Inventors: Ganga Raju Gokaraju, Rama Raju Gokaraju, Trimurtulu Golakoti, Krishanu Sengupta, Kiran Bhupathiraju, Venkata Krishna Raju Alluri
-
Publication number: 20100189806Abstract: Methods of growing and harvesting multiple species of phytoplankton are disclosed herein. The method generally includes four steps, namely: (1) collecting phytoplankton seawater containing multiple species of naturally-occurring phytoplankton directly from a source of seawater; (2) adding nutrients to the phytoplankton seawater to proliferate the multiple species of naturally-occurring phytoplankton to a predetermined density; (3) separating the multiple species of naturally-occurring phytoplankton from the phytoplankton seawater to form a phytoplankton concentrate; and (4) collecting the phytoplankton concentrate such that the collected phytoplankton of the phytoplankton concentrate remain in a substantially intact cellular state.Type: ApplicationFiled: October 21, 2009Publication date: July 29, 2010Inventors: Margaret Harper, Arturo Ramirez
-
Publication number: 20100178362Abstract: A method of treating impaired memory and/or cognitive function by administering one or more chromium complexes, for example chromium picolinate, to an individual in need of improved memory and/or cognitive function. This method is used to improve memory and/or cognitive function associated with various disorders, including Alzheimer's disease, dementia, and mild cognitive impairment (MCI). Chromium complexes for treating memory or cognitive impairment are also disclosed.Type: ApplicationFiled: January 5, 2010Publication date: July 15, 2010Inventors: James R. Komorowski, Vijaya Juturu
-
Patent number: 7749547Abstract: A dietary supplement with Creatine, Taurine and a source of Phosphate. The dietary supplement may further include one or more of Double Fermented Triticum aestivum, Dextrose, Isomalt, Trehalose, D-Mannose, Mulberry extract, Enicostemma littorale Blume, Scoparia dulcis, Tarragon extract, Andrographis paniculata, Chromium, Glutamine and Alpha Lipoic Acid. Administered in the morning or following exercise, the dietary supplement increases Creatine uptake and retention in skeletal muscle, muscle mass and strength, exercise capacity and aids in recovery following exercise as well as supporting the immune system during periods of intense training.Type: GrantFiled: September 14, 2006Date of Patent: July 6, 2010Assignee: New Cell Formulations Ltd.Inventors: Marvin A. Heuer, Kenneth Clement, Shan Chaudhuri, James D. Ramsbottom, Megan K. Thomas
-
Publication number: 20100150895Abstract: This invention describes a comprehensive nutraceutical designed to antagonize major mitigating factors to the degenerative process associated with Parkinson's disease. The formulation is comprised of a primary base of pyruvate, succinate, ?-Ketoglutarate and/or oxaloacetate, niacin/NADH, fruit extracts, anthocyanins, further combined with specific macro/micronutrients, trace elements, amino acids, flavonoids and concentrated plant sources. The nutraceutical contains all natural substances that should mitigate many of the neurodegenerative processes known to be associated with PD. Mechanisms addressed are to prevent the loss of ATP/by 1-methyl-4-phenylpyridinium rotenone, scavenge hydrogen peroxide/O2.Type: ApplicationFiled: February 6, 2010Publication date: June 17, 2010Inventors: Elizabeth Mazzio, Karam Soliman
-
Publication number: 20100151045Abstract: A method is provided for reducing side effects while treating a mammal using indole-3-carbinol, which method includes the steps of administering an effective amount of indole-3-carbinol along with side effect-reducing amounts of a side-effect reducing component. A composition is also provided, as are various combinations of side effect-reducing agents.Type: ApplicationFiled: February 22, 2010Publication date: June 17, 2010Inventor: James H. Zhou
-
Publication number: 20100136133Abstract: The invention provides intradialytic parenteral nutrition (IDPN) solutions with low carbohydrate for the treatment of malnutrition in dialysis patients. The IDPN solutions of the invention are particularly advantageous for the treatment of malnutrition in patients who are diabetic or suffer from other glucose management related pathologies or patients who require strict fluid management.Type: ApplicationFiled: July 7, 2009Publication date: June 3, 2010Inventors: Eileen Moore, Stan Lindenfeld, Michelle Ricker
-
Publication number: 20100080856Abstract: A composition and a method for administering the composition to a patient in order to accelerate wound healing, particularly postoperative wound healing. The composition, which essentially comprises ornithine ?-ketoglutarate, is water-soluble and formulated for oral administration in single-dose packets. The method for using the composition for promoting wound healing includes the step of administering the composition to a patient preoperatively as well as-postoperatively in accordance with a prescribed protocol. The composition may be customized to include one or more additional agents that are effective for promoting nutritional health and/or treating a particular medical problem. The composition may also be taken daily by athletes to minimize the healing time of closed wounds such as muscle or tendon tears that occur during participation in sports, even when the symptoms of such injury are subclinical.Type: ApplicationFiled: September 26, 2008Publication date: April 1, 2010Inventor: Peter D. Costantino
-
Publication number: 20100074968Abstract: The invention relates to the treatment and prophylaxis of cancer. In particular, the invention relates to a pharmaceutical agent comprising strontium, amino acid(s) and mineral element(s), and its use in the preparation of an agent useful for the treatment and prophylaxis of cancer. The invention also relates to a method for treatment and prophylaxis of cancer.Type: ApplicationFiled: November 30, 2009Publication date: March 25, 2010Inventor: Thomas TALLBERG
-
Publication number: 20100074881Abstract: A device for administering two or more therapeutic agents simultaneously, comprising two or more nebulizers and a single connector linking the nebulizers to a nebulizer mouthpiece. Also provided is a method of administering two or more therapeutic agents simultaneously, comprising administering the therapeutic agents simultaneously with the device of the present invention to a subject in need thereof.Type: ApplicationFiled: July 13, 2009Publication date: March 25, 2010Applicant: PARION SCIENCES, Inc.Inventors: Richard C. BOUCHER, Michael R. Johnson, Keith A. Johnson, William R. Thelin
-
Publication number: 20100074969Abstract: A nutrient fiber matrix and associated methods that help control blood sugar levels is described. The matrix can control blood sugar in a variety of ways. In one possible example, the matrix blocks carbohydrates in a manner that reduces the body's ability to take the carbohydrates into its cells. In another example, the matrix acts to increase a person's energy level and feelings of satiety. Thus, the matrix can reduce the person's desire to consume more food and, thereby, help the person to keep from increasing his or her blood sugar levels by eating more. In still another example, the fiber matrix helps sugars to be absorbed over a longer period of time so as to smooth out and prevent spikes in blood sugar levels.Type: ApplicationFiled: September 21, 2009Publication date: March 25, 2010Applicant: UNICITY INTERNATIONAL, INC.Inventors: Stewart F. Hughes, Curtis A. Hedges, G. Paulo Bangerter
-
Publication number: 20100062087Abstract: In an embodiment of the present invention, a nutraceutical formula comprising a combination of two or more substances from the group: berry extract, chromium, zinc, trans-resveratrol, l-arginine, chlorophyll, vitamin C and aloe vera combined synergistically to reduce inflammation in mammals suffering from diabetes. In another embodiment of the present invention, a nutraceutical formula comprising a combination of two or more substances from the group: berry extract, chromium, zinc, fr-??s-resveratrol, l-arginine, chlorophyll, vitamin C and aloe vera combined synergistically to enhance wound healing in mammals suffering from diabetes. In an alternative embodiment of the present invention, a nutraceutical formula comprising a combination of two or more substances from the group: berry extract, chromium, zinc, trans-resveratrol, l-arginine, chlorophyll, vitamin C and aloe vera combined synergistically to reduce inflammation in mammals not suffering from diabetes.Type: ApplicationFiled: June 4, 2007Publication date: March 11, 2010Applicant: Interhealth Nutraceuticals, Inc.Inventors: Xiaoming Xu Chien, Debasis Bagchi
-
Publication number: 20100015118Abstract: A body supplement and method for improving blood flow, muscle chemistry and/or the oxygenation of muscles, said supplement including cinchona bark or quinine in the range of approximately 0.0010 grams and 4.0 grams per dosage.Type: ApplicationFiled: July 15, 2009Publication date: January 21, 2010Inventors: Anthony J. Hadala, Lewis E. Bennett, D.C.
-
Publication number: 20100009014Abstract: The present invention relates to use of a composition for the manufacture of a medicament and a method for inhibiting the formation of body fat. The composition includes lactoferrin and a trivalent chromium compound. Herein, the chromium compound is selected from the group consisting of chromium (III) chloride hexahydrate, chromium (III) chloride, chromium (III) acetate, chromium (III) sulfate, chromium picolinate, chromium nicotinate, chromium GTF, chromium yeast extract, other inorganic salts of trivalent chromium, other organic salts of trivalent chromium, and combinations thereof. Accordingly, the composition of the present invention can assist in transmitting glucose from cells to muscle tissues and thereby reducing the storage of fat converted from glucose to achieve the purpose of controlling body weight.Type: ApplicationFiled: June 24, 2009Publication date: January 14, 2010Applicant: Maxluck Biotechnology Corp.Inventors: Frank Chiahung Mao, Wen-Ying Chen, Chi-Ching Sun, Chia-Hsin Liu
-
Publication number: 20100009015Abstract: Provided herein are methods for treating, preventing, and improving conditions associated with cardiometabolic syndrome, by identifying a subject in need of treatment, prevention, or improvement of a condition associated with cardiometabolic syndrome, and providing a therapeutically effective amount of a composition comprising chromium and histidine, chromium histidinate complexes, or combinations thereof, to the individual.Type: ApplicationFiled: July 30, 2009Publication date: January 14, 2010Inventors: Vijaya Juturu, James Komorowski
-
Publication number: 20100003347Abstract: A composition for preventing and treating fatty liver is disclosed. The composition includes a lactoferrin and a trivalent chromium compound. The trivalent chromium compound of the present invention is selected from the group consisting of chromium (III) chloride hexahydrate, chromium (III) chloride, chromium (III) acetate, chromium (III) sulfate, chromium picolinate, chromium nicotinate, chromium GTF, chromium yeast extract, other inorganic salts of trivalent chromium, other organic salts of trivalent chromium, and combinations thereof. The composition of the present invention can provide a beneficial effect in preventing and treating fatty liver by effectively reducing multiple risk factors of fatty liver disease.Type: ApplicationFiled: June 29, 2009Publication date: January 7, 2010Applicant: National Chung Hsing UniversityInventors: Frank Chiahung Mao, Wen-Ying Chen
-
Publication number: 20090280192Abstract: Disclosed is a method for treating or preventing Alzheimer's disease by restricting the level of metabolizable carbohydrate in the diet and/or administering to the patient an effective amount of an agent which reduces serum insulin levels.Type: ApplicationFiled: July 20, 2009Publication date: November 12, 2009Inventors: Robert W. Esmond, Jack R. Wands
-
Publication number: 20090263505Abstract: A daily dietary supplement for improving glucose metabolism, said dietary supplement comprising: an effective amount of a source of Alpha Lipoic Acid; an effective amount of a source of Salacia Oblonga; an effective amount of a source of Gymnema Sylvestre; an effective amount of a source of Chromium; an effective amount of a source of Cinnamon, an effective amount of a source of Banaba; and an effective amount of a source of Fenugreek.Type: ApplicationFiled: April 19, 2009Publication date: October 22, 2009Inventor: George Roderick Hammons
-
Patent number: RE40849Abstract: Glutathione (GSH) is a tripeptide of extreme importance as a catalyst, reductan, and reactant. It can be depleted intracellulary either by forming a direct complex with an electrophilic agent (accomplished investigationally by agents such as bromobenzene or diethyl maleate), by way of inhibition of synthesis, or by subjecting cells to oxidant stress. Most cells, except for epithelia cells, do not have a direct transport capacity for intact GSH. Non-epithelial cells must either transport precursor substrates for GSH synthesis or salvage amino acids from circulating GSH for reuse in intracellular resynthesis. Dietary cysteine is a rate limiting substrate for the synthesis of glutathione and also inhibits GSH efflux. Although GSH is synthesized from precursors in virtually all cells, the liver is the main source of plasma GSH. Protection and support of liver function is paramount to elevating GSH levels.Type: GrantFiled: January 9, 2007Date of Patent: July 14, 2009Assignee: Vit Immune, L.C.Inventors: Robert H. Keller, David W. Kirchenbaum